Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7063)
All Articles published online
|
Publishing Process of This Article
|
Apr 21, 2015 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jiang JH, Guo Z, Lu HF, Wang XB, Yang HJ, Yang FQ, Bao SY, Zhong JH, Li LQ, Yang RR, Xiang BD. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: Propensity score analysis. World J Gastroenterol 2015; 21(15): 4627-4634 [PMID: 25914472 DOI: 10.3748/wjg.v21.i15.4627] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i15/4627.htm |
| Number | Citing Articles |
| 1 |
Qizhen Huang, Kongying Lin, Lei Wang, Jianxing Zeng, Hongzhi Liu, Zongren Ding, Yongyi Zeng, Jingfeng Liu. <p>Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study</p>. Cancer Management and Research 2020; : 9183 doi: 10.2147/CMAR.S270467
|
| 2 |
Yu-Fei Zhao, Xiu Xiong, Kai Chen, Wei Tang, Xu Yang, Zheng-Rong Shi. Evaluation of the Therapeutic Effect of Adjuvant Transcatheter Arterial Chemoembolization Based on Ki67 After Hepatocellular Carcinoma Surgery. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.605234
|
| 3 |
Chu-Yu Jing, Yi-Peng Fu, Su-Su Zheng, Yong Yi, Hu-Jia Shen, Jin-Long Huang, Xin Xu, Jia-Jia Lin, Jian Zhou, Jia Fan, Zheng-Gang Ren, Shuang-Jian Qiu, Bo-Heng Zhang. Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection. Medicine 2017; 96(11): e6140 doi: 10.1097/MD.0000000000006140
|
| 4 |
Rui-Sheng Ke, Qiu-cheng Cai, Yong-tai Chen, Li-Zhi Lv, Yi Jiang. Diagnosis and treatment of microvascular invasion in hepatocellular carcinoma. European Surgery 2020; 52(2): 55 doi: 10.1007/s10353-019-0573-1
|
| 5 |
A Lei Feng, Jian Kang Zhu, Yupeng Yang, Ya Dong Wang, Feng Yue Liu, Min Zhu, Chong Zhong Liu. Repeated postoperative adjuvant TACE after curative hepatectomy improves outcomes of patients with HCC. Minimally Invasive Therapy & Allied Technologies 2021; 30(3): 163 doi: 10.1080/13645706.2019.1707689
|
| 6 |
Cailing Xiang, Xianbo Shen, Xinxin Zeng, Yuzhong Zhang, Zhongzhi Ma, Guocan Zhang, Xin Song, Tao Huang, Juan Yang. Effect of transarterial chemoembolization as postoperative adjuvant therapy for intermediate-stage hepatocellular carcinoma with microvascular invasion: a multicenter cohort study. International Journal of Surgery 2024; 110(1): 315 doi: 10.1097/JS9.0000000000000805
|
| 7 |
Hao-Jie Yang, Zhe Guo, Yu-Ting Yang, Jing-Hang Jiang, Ya-Peng Qi, Ji-Jia Li, Le-Qun Li, Bang-De Xiang. Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis. World Journal of Gastroenterology 2016; 22(21): 5088-5095 doi: 10.3748/wjg.v22.i21.5088
|
| 8 |
Ya-Peng Qi, Jian-Hong Zhong, Zhi-Yin Liang, Jie Zhang, Bin Chen, Chang-Zhi Chen, Le-Qun Li, Bang-De Xiang. Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion. The American Journal of Surgery 2019; 217(4): 739 doi: 10.1016/j.amjsurg.2018.07.054
|
| 9 |
Wen Chen, Tao Ma, Jian Zhang, Xiaozhen Zhang, Wei Chen, Yinan Shen, Xueli Bai, Tingbo Liang. A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinoma. HPB 2020; 22(6): 795 doi: 10.1016/j.hpb.2019.12.013
|
| 10 |
Ya Ruth Huo, Michael Vinchill Chan, Christine Chan. Resection Plus Post-operative Adjuvant Transcatheter Arterial Chemoembolization (TACE) Compared with Resection Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. CardioVascular and Interventional Radiology 2020; 43(4): 572 doi: 10.1007/s00270-019-02392-6
|
| 11 |
Jing-Xuan Xu, Shui-Ling Qin, Hao-Wen Wei, Yuan-Yuan Chen, Yu-Chong Peng, Lu-Nan Qi. Prognostic factors and an innovative nomogram model for patients with hepatocellular carcinoma treated with postoperative adjuvant transarterial chemoembolization. Annals of Medicine 2023; 55(1) doi: 10.1080/07853890.2023.2199219
|
| 12 |
Jingzhong Ouyang, Zhengzheng Wang, Kun Yuan, Yi Yang, Yanzhao Zhou, Qingjun Li, Nanmu Yang, Haitao Zhao, Hong Zhao, Jinxue Zhou. Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis. Journal of Hepatocellular Carcinoma 2023; : 1465 doi: 10.2147/JHC.S424616
|
| 13 |
Shuang Liu, Hui Li, Lei Guo, Bo Zhang, Binghai Zhou, Wentao Zhang, Jian Zhou, Jia Fan, Qinghai Ye. Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion. The Oncologist 2019; 24(4): 513 doi: 10.1634/theoncologist.2018-0305
|
| 14 |
Kevin P. Labadie, Jonathan G. Sham. Adjuvant Transcatheter Arterial Infusion Therapy for Hepatocellular Carcinoma: Not Yet for Everybody. Annals of Surgical Oncology 2020; 27(11): 4070 doi: 10.1245/s10434-020-08702-4
|
| 15 |
Yuxin Liang, Zirui Wang, Yujiao Peng, Zonglin Dai, Chunyou Lai, Yuqin Qiu, Yutong Yao, Ying Shi, Jin Shang, Xiaolun Huang. Development of ensemble learning models for prognosis of hepatocellular carcinoma patients underwent postoperative adjuvant transarterial chemoembolization. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1169102
|
| 16 |
T. Hamada, K. Yano, T. Wada, N. Imamura, M. Hiyoshi, K. Kondo, Atsushi Nanashima. Increased Survival Benefit of Adjuvant Intra‐arterial Infusion Chemotherapy in HCC Patients with Portal Vein Infiltration after Hepatectomy. World Journal of Surgery 2020; 44(8): 2770 doi: 10.1007/s00268-020-05527-w
|
| 17 |
Zhe Guo, Yuan Zhong, Bo Hu, Jing-Hang Jiang, Le-Qun Li, Bang-De Xiang. Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma within Milan criteria. Medicine 2017; 96(51): e8933 doi: 10.1097/MD.0000000000008933
|
| 18 |
Jian Huang, Fu-Chen Liu, Li Li, Sheng-Xian Yuan, Yuan Yang, Bei-Ge Jiang, Hui Liu, Ze-Ya Pan. Prognostic Nomogram for Hepatitis B Virus–related Hepatocellular Carcinoma With Adjuvant Transarterial Chemoembolization After Radical Resection. American Journal of Clinical Oncology 2020; 43(1): 20 doi: 10.1097/COC.0000000000000619
|
| 19 |
Peng‐Xiang Wang, Yun‐Fan Sun, Kai‐Qian Zhou, Jian‐Wen Cheng, Bo Hu, Wei Guo, Yue Yin, Jun‐Feng Huang, Jian Zhou, Jia Fan, Tan To Cheung, Xu‐Dong Qu, Xin‐Rong Yang. Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single‐center, retrospective, propensity‐matched study. Clinical and Translational Medicine 2020; 10(3) doi: 10.1002/ctm2.137
|
| 20 |
Shi-Dong Lu, Lin Li, Xin-Min Liang, Wu Chen, Fu-Li Chen, Lang-Lin Fan, Bhavesh K. Ahir, Wan-Guang Zhang, Jian-Hong Zhong. Updates and advancements in the management of hepatocellular carcinoma patients after hepatectomy. Expert Review of Gastroenterology & Hepatology 2019; 13(11): 1077 doi: 10.1080/17474124.2019.1684898
|
| 21 |
Freliska Lazuardi, Jacqueline Valencia, Shusen Zheng. Adjuvant transcatheter arterial chemoembolization after radical resection of hepatocellular carcinoma patients with tumor size less than 5 cm: a retrospective study. Scandinavian Journal of Gastroenterology 2019; 54(5): 617 doi: 10.1080/00365521.2019.1607896
|
| 22 |
Jingxian Gu, Xing Zhang, Ruixia Cui, Jia Zhang, Zhixin Wang, Yifan Jia, Runchen Miao, Yanyan Dong, Xiaohua Ma, Haining Fan, Haijiu Wang, Li Ren, Yiming Li, Wenquan Niu, Jingyao Zhang, Kai Qu, Chang Liu. Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization. European Journal of Gastroenterology & Hepatology 2019; 31(7): 836 doi: 10.1097/MEG.0000000000001346
|
| 23 |
WEN-FENG GONG, JIAN-HONG ZHONG, BANG-DE XIANG, LE-QUN LI. Feasibility of combining adjuvant transarterial chemoembolization with nucleos(t)ide analog therapy for patients with HBV-associated hepatocellular carcinoma after hepatectomy. Molecular and Clinical Oncology 2016; 5(1): 3 doi: 10.3892/mco.2016.871
|
| 24 |
Hao-Jie Yang, Jing-Hang Jiang, Yu-Ting Yang, Zhe Guo, Ji-jia Li, Xuan-han Liu, Fei Lu, Feng-Hua Zeng, Jin-Song Ye, Ke-Lan Zhang, Neng-Zhi Chen, Bang-De Xiang, Le-Qun Li. Stratified aspartate aminotransferase-to-platelet ratio index accurately predicts survival in hepatocellular carcinoma patients undergoing curative liver resection. Tumor Biology 2017; 39(3): 101042831769594 doi: 10.1177/1010428317695944
|
| 25 |
Rong-yun Mai, Jie Zeng, Wei-da Meng, Hua-ze Lu, Rong Liang, Yan Lin, Guo-bin Wu, Le-qun Li, Liang Ma, Jia-zhou Ye, Tao Bai. Artificial neural network model to predict post-hepatectomy early recurrence of hepatocellular carcinoma without macroscopic vascular invasion. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-07969-4
|
| 26 |
Guifang Zeng, Baojia Zou, Yongliang Li, En Lin, Xialei Liu, Peiping Li, Jiafan Chen, Baimeng Zhang, Yingbin Jia, Chaonong Cai, Jian Li. Efficacy of Adjuvant Transarterial Chemoembolization after Radical Hepatectomy in Solitary Hepatocellular Carcinoma Patients: A Retrospective Study. Journal of Investigative Surgery 2022; 35(6): 1208 doi: 10.1080/08941939.2021.2021334
|
| 27 |
Wentao Wang, Yaxun Guo, Jingtao Zhong, Qi Wang, Xin Wang, Honglong Wei, Jie Li, Peng Xiu. The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-82058-x
|
| 28 |
Kelvin K. Ng, Tan-To Cheung, Herbert H. Pang, Tiffany C. Wong, Jeff W. Dai, Ka-Wing Ma, Wong-Hoi She, C.Nicholas Kotewall, Chung-Mau Lo. A simplified prediction model for early intrahepatic recurrence after hepatectomy for patients with unilobar hepatocellular carcinoma without macroscopic vascular invasion: An implication for adjuvant therapy and postoperative surveillance. Surgical Oncology 2019; 30: 6 doi: 10.1016/j.suronc.2019.05.017
|
| 29 |
Jian-Hong Zhong, Ling-Hui Pan, Yan-Yan Wang, Alessandro Cucchetti, Tian Yang, Xue-Mei You, Liang Ma, Wen-Feng Gong, Bang-De Xiang, Ning-Fu Peng, Fei-Xiang Wu, Le-Qun Li. Optimizing stage of single large hepatocellular carcinoma. Medicine 2017; 96(15): e6608 doi: 10.1097/MD.0000000000006608
|
| 30 |
Xiaofeng Zhang, Jun Li, Feng Shen, Wan Yee Lau. Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2018; 33(2): 347 doi: 10.1111/jgh.13843
|
| 31 |
Lei Wang, Qiao Ke, Manjun Deng, Xin Huang, Jianxing Zeng, Hongzhi Liu, Yuan Yang, Yongyi Zeng, Weiping Zhou, Jingfeng Liu. Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma after radical hepatectomy: a real world study. Scandinavian Journal of Gastroenterology 2019; 54(11): 1403 doi: 10.1080/00365521.2019.1684986
|
| 32 |
Juqiang Zhang, Hao Peng, Botian Wang, Lei Luo, Yuan Cheng, Guolin He, Yujun Tang, MingXin Pan. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients with Mesenchymal Circulating Tumor Cell. Journal of Gastrointestinal Surgery 2021; 25(7): 1770 doi: 10.1007/s11605-020-04755-8
|
| 33 |
Fang Wang, Gan Zhan, Qing‐qing Chen, Hou‐yun Xu, Dan Cao, Yuan‐yuan Zhang, Yin‐hao Li, Chu‐jie Zhang, Yao Jin, Wen‐bin Ji, Jian‐bing Ma, Yun‐jun Yang, Wei Zhou, Zhi‐yi Peng, Xiao Liang, Li‐ping Deng, Lan‐fen Lin, Yen‐wei Chen, Hong‐jie Hu. Multitask deep learning for prediction of microvascular invasion and recurrence‐free survival in hepatocellular carcinoma based on MRI images. Liver International 2024; doi: 10.1111/liv.15870
|
| 34 |
Xuejun Kuang, Jiazhou Ye, Zhibo Xie, Tao Bai, Jie Chen, Wenfeng Gong, Lunan Qi, Jianhong Zhong, Liang Ma, Ningfu Peng, Bangde Xiang, Feixiang Wu, Guobin Wu, Haihong Ye, Changmiao Wang, Lunqun Li. Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection. Oncology Letters 2018; doi: 10.3892/ol.2018.9244
|
| 35 |
Weili Qi, Wei Peng, Xin Qi, Zhancheng Qiu, Tianfu Wen, Chuan Li. TIDE: adjuvant tislelizumab plus donafenib combined with transarterial chemoembolization for high-risk hepatocellular carcinoma after surgery: protocol for a prospective, single-arm, phase II trial. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1138570
|
| 36 |
Hao Su, Guangzhi Zhu, Ketut Indra Djaja P, Yi Lin, Yizhen Gong, Xiaoguang Liu, Jiaquan Li, Zhiming Liu, Xiao Qin, Lequn Li, Tangwei Liu, Zili Lu, Minyi Wei, Lunan Yan, Cheryl Ann Winkler, Stephen J. O’Brien, Jing Li, Kaiyin Xiao, Tao Peng. Preoperative transcatheter arterial chemotherapy may suppress oxidative stress in hepatocellular carcinoma cells and reduce the risk of short-term relapse. Oncotarget 2017; 8(33): 54402 doi: 10.18632/oncotarget.17660
|
| 37 |
Qinghua Shu, Nannan Zhang, Jianbo Han, Xiaopeng Yan, Bowen Sha, Liang Zhao, Yongxiang Yi, Yufeng Zhang. Novel predictive nomograms based on aspartate aminotransferase‑to‑platelet ratio index for hepatocellular carcinoma with post‑operative adjuvant transarterial chemoembolization. Oncology Letters 2023; 27(1) doi: 10.3892/ol.2023.14137
|
| 38 |
Mingheng Liao, Zexin Zhu, Haichuan Wang, Jiwei Huang. Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis. Scandinavian Journal of Gastroenterology 2017; 52(6-7): 624 doi: 10.1080/00365521.2017.1292365
|
| 39 |
Song-Lin Ma, Yang Lv, Jing-Hang Jiang. Efficacy of combined adjuvant transarterial chemoembolization and antiviral therapy in patients with HBV-related hepatocellular carcinoma after surgery. Tumor Biology 2015; 36(10): 7395 doi: 10.1007/s13277-015-4026-6
|
| 40 |
Lei Liang, Chao Li, Yong-Kang Diao, Hang-Dong Jia, Hao Xing, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Dong-Sheng Huang, Cheng-Wu Zhang, Tian Yang. Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis. Therapeutic Advances in Gastroenterology 2020; 13: 175628482097769 doi: 10.1177/1756284820977693
|
| 41 |
Jiang Jiang, Hao Hu, Rong Liu, Jian Hua Wang, Xiao Ran Long, Jia Fan, Zhi Ping Yan. Nomogram for individualized prediction of recurrence after postoperative adjuvant TACE for hepatitis B virus-related hepatocellular carcinoma. Medicine 2017; 96(32): e7390 doi: 10.1097/MD.0000000000007390
|